Behavioral intervention boosts physical activity in breast cancer survivors
the ONA take:
The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) trial was a multicenter trial including 692 overweight or obese women who had breast cancer.
Obesity is known to increase risk for all-cause mortality and breast cancer mortality among women in whom the disease was diagnosed and treated. This study is the largest trial on weight loss intervention among survivors of breast cancer.
The women had undergone primary treatment for early stage breast cancer, on average, 2 years before enrollment in the study.
They were randomly assigned to a group-based behavior intervention, including telephone counseling and tailored newsletters, or a less intensive control intervention. Both groups were observed for 2 years, with weight and blood pressure measurements taken at 6, 12, 18, and 24 months.
At 12 months, weight loss was greater in the intervention group than in the control group (6.0% of initial weight vs. 1.5%, respectively).
At 24 months, weight loss was also greater in the intervention group (3.7%) compared with the control group (1.3%). Effects on physical activity and blood pressure were favorable in the intervention group as well.
The study findings demonstrated that a behavioral weight loss intervention can produce clinically meaningful weight loss in overweight/obese breast cancer survivors.
Further studies are needed to test methods for sustained weight loss and to determine the potential benefits of intentional weight loss in this patient population.
A behavioral weight loss intervention can produce clinically meaningful weight loss in overweight/obese breast cancer survivors.
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Vitamin D Supplementation is Recommended for Pediatric Patients With Sarcoma
- Extended Adjuvant Therapy for Breast Cancer Improves 5-Year Disease-free Survival
- A Structured Group Exercise Program for Patients With Metastatic Cancer Receiving Chemotherapy and CTNNB1 (β-catenin) as a Biomarker of Exercise Efficacy
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|